Association of serum albumin concentration with mortality, morbidity, CD4 T-cell reconstitution among tanzanians initiating antiretroviral therapy

Journal of Infectious Diseases

Volumn 207, Issue 9, 2013, Pages 1370-1378

  Sudfeld, Christopher R ^a   Isanaka, Sheila ^b   Aboud, Said ^c   Mugusi, Ferdinand M ^c   Wang, Molin ^b   Chalamilla, Guerino E ^b,d   Fawzi, Wafaie W ^a,b  

^a Bldg 1 ^*  (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^d MANAGEMENT AND DEVELOPMENT FOR HEALTH   (Tanzania)

Author keywords

albumin; HIV; mortality; nutrition; tuberculosis

Indexed keywords

ALBUMIN; ANTIRETROVIRUS AGENT; MULTIVITAMIN;

ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ANTHROPOMETRY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOALBUMINEMIA; INCIDENCE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; TANZANIA; WASTING SYNDROME; WEIGHT REDUCTION;

ADULT; ANTI-RETROVIRAL AGENTS; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; SERUM ALBUMIN; SURVIVAL ANALYSIS; TANZANIA; TREATMENT OUTCOME; VITAMINS; YOUNG ADULT;

EID: 84876010432     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jit027     Document Type: Article

References (39)

1. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4 lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126:946-54. (Pubitemid 27255797)
2. Mekonnen Y, Dukers NH, Sanders E, et al. Simple markers for initiating antiretroviral therapy among HIV-infected Ethiopians. AIDS 2003; 17:815-9. (Pubitemid 36547653)
3. Joles JA, Willekes-Koolschijn N, Koomans HA. Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine. Kidney Int 1997; 52:761-70. (Pubitemid 27402377)
4. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004; 17:432-7. (Pubitemid 40110428)
5. Chan JC, Tsui EL, Wong VC, Hospital Authority SARS Collaborative Group. Prognostication in severe acute respiratory syndrome: a retrospective time-course analysis of 1312 laboratory-confirmed patients in Hong Kong. Respirology 2007; 12:531-42. (Pubitemid 46961829)
6. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989; 2:1434-6. (Pubitemid 20012066)
7. Franch-Arcas G. The meaning of hypoalbuminaemia in clinical practice. Clin Nutr 2001; 20:265-9. (Pubitemid 32700793)
8. Menon V, Greene T, Wang X, et al. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int, 2005; 68:766-72. (Pubitemid 43323132)
9. Sabin CA, Griffioen A, Yee TT, et al. Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: A longitudinal study. Lancet 2002; 360:1546-51. (Pubitemid 35356369)
10. Feldman JG, Gange SJ, Bacchetti P, et al. Serum albumin is a powerful predictor of survival among HIV-1-infected women. J Acquir Immune Defic Syndr 2003; 33:66-73. (Pubitemid 36547243)
11. Shah S, Smith CJ, Lampe F, et al. Haemoglobin and albumin as markers of HIV disease progression in the highly active antiretroviral therapy era: relationships with gender. HIV Med 2007; 8:38-45. (Pubitemid 46117840)
12. Mehta SH, Astemborski J, Sterling TR, Thomas DL, Vlahov D. Serum albumin as a prognostic indicator for HIV disease progression. AIDS Res Hum Retroviruses 2006; 22:14-21. (Pubitemid 43201512)
13. Dao CN, Peters PJ, Kiarie JN, et al. Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women. AIDS Res Hum Retroviruses 2011; 27:1149-55.
14. Graham SM, Baeten JM, Richardson BA, et al. A decrease in albumin in early HIV type 1 infection predicts subsequent disease progression. AIDS Res Hum Retroviruses 2007; 23:1197-200. (Pubitemid 350014771)
15. Baeten JM, McClelland RS, Wener MH, et al. Relationship between markers of HIV-1 disease progression and serum beta-carotene concentrations in Kenyan women. Int J STD AIDS 2007; 18:202-6. (Pubitemid 351760819)
16. Olawumi HO, Olatunji PO. The value of serum albumin in pretreatment assessment and monitoring of therapy in HIV/AIDS patients. HIV Med 2006; 7:351-5. (Pubitemid 44123244)
17. Isanaka S, Mugusi M, Hawkins C, et al. Effect of high-dose multivitamin supplementation at the initiation of HAART on HIV disease progression and mortality in Tanzania: a randomized controlled trial. JAMA 2012; 308:1535-44.
18. World Health Organization. Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. Geneva: World Health Organization, 2004.
19. Enarson DA, Rieder HL, Arnadottir T, Trébucq A. Management of tuberculosis. A guide for low income countries. 5th ed. Paris, France: International Union Against Tuberculosis and Lung Disease, 2000.
20. World Health Organization Expert Committee. Physical status: the use and interpretation of anthropometry. WHO Technical Report Series 854. Geneva: World Health Organization, 1995.
21. Polsky B, Kotler D, Steinhart C. HIV-associated wasting in the HAART era: Guidelines for assessment, diagnosis, and treatment. AIDS Patient Care STDs 2001; 15:411-23. (Pubitemid 32762700)
22. World Health Organization. Nutritional anaemias. Report of a WHO Scientific Group. WHO Techn Rep Ser 1968; 405:9-10.
23. Dati F, Schumann G, Thomas L, et al. Consensus of a group of professional societies and diagnostic companies on guidelines for interim reference ranges for 14 proteins in serum based on the standardization against the IFCC/BCR/CAP Reference Material (CRM 470) International Federation of Clinical Chemistry. Community Bureau of Reference of the Commission of the European Communities. College of American Pathologists. Eur J Clin Chem Clin Biochem 1996; 34:517-20.
24. Wacholder S. Binomial regression in GLIM: Estimating risk ratios and risk differences. Am J Epidemiol 1986; 123:174-84. (Pubitemid 16189710)
25. Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005; 162:199-200. (Pubitemid 41373523)
26. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159:702-6. (Pubitemid 38405384)
27. Cox D. Regression models and life tables. J Royal Stat Soc 1972; 34:187-220.
28. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8:551-61. (Pubitemid 19116001)
29. Govindarajulu US, Spiegelman D, Thurston SW, Ganguli B, Eisen EA. Comparing smoothing techniques in Cox models for exposure-response relationships. Stat Med 2007; 26:3735-52. (Pubitemid 47307746)
30. Miettinen O. Theoretical epidemiology. New York: John Wiley & Sons, 1985.
31. Robson SC, White NW, Aronson I, Woollgar R, Goodman H, Jacobs P. Acute phase response and the hypercoagulable state in pulmonary tuberculosis. Br J Haematol 1996; 93:943-9. (Pubitemid 26199339)
32. Evans CA, Jellis J, Hughes SP, Remick DG, Friedland JS. Tumor necrosis factor alpha, interleukin 6 and interleukin 8 secretion and the acute phase response in patients with bacterial and tuberculous osteomyelitis. J Infect Dis 1998; 177:1582-7. (Pubitemid 28243582)
33. Worodria W, Massinga-Loembe M, Mayanja-Kizza H, et al. Antiretroviral treatment-associated tuberculosis in a prospective cohort of HIV-infected patients starting ART. Clin Dev Immunol 2011; 2011:758350.
34. Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73:391-8. (Pubitemid 351186278)
35. Yeun JY, Kaysen GA. Factors influencing serum albumin in dialysis patients. Am J Kidney Dis 1998; 32:S118-25.
36. Agarwal R, Davis JL, Smith L. Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3:98-104.
37. Bindra K, Berry C, Rogers J, et al. Abnormal haemoglobin levels in acute coronary syndromes. QJM 2006; 99:851-62. (Pubitemid 46024096)
38. Covinsky KE, Covinsky MH, Palmer RM, Sehgal AR. Serum albumin concentration and clinical assessments of nutritional status in hospitalized older people: different sides of different coins? J Am Geriatr Soc 2002; 50:631-7. (Pubitemid 34298750)
39. Dusingize JC, Hoover DR, Shi Q, et al. Association of serum albumin with markers of nutritional status among HIV-infected and uninfected Rwandan women. PLoS One 2012; 7:e35079.